Search
Menu
Spectrogon US - Optical Filters 2024 LB

Lensar System Receives FDA Clearance

Facebook X LinkedIn Email
Ocular laser developer Lensar Inc. has received 510(k) clearance from the U.S. FDA for its LENSAR laser system with Streamline IV, expanding the platform’s capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures treating presbyopia. With the new indications, the LENSAR laser system now supports surgeons offering the latest presbyopic inlay devices to patients struggling with the loss of near vision due to aging. “The continued expansion of capabilities with the LENSAR laser system is the latest demonstration of our commitment...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2018
    BusinessLensarU.S. Food and Drug AdministrationLensar Laser SystemStreamline IVAmericasBiophotonicsRapidScan

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.